购物车
全部删除
您的购物车当前为空
别名 依决洛单抗, Panorex, M-17-1A, CO17-1A, CO171A, 17-1A, 1083 17-1A
Edrecolomab (Panorex) 是靶向细胞表面糖蛋白 17-1A 的鼠源抗体,具有抗肿瘤活性,可识别人肿瘤相关抗原 Ep-CAM,可用于研究结直肠癌。
Edrecolomab (Panorex) 是靶向细胞表面糖蛋白 17-1A 的鼠源抗体,具有抗肿瘤活性,可识别人肿瘤相关抗原 Ep-CAM,可用于研究结直肠癌。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,320 | 现货 | |
| 5 mg | ¥ 5,490 | 现货 | |
| 10 mg | ¥ 7,480 | 现货 | |
| 25 mg | ¥ 10,900 | 现货 |
| 产品描述 | Edrecolomab (Panorex) is a murine monoclonal antibody targeting the cell surface glycoprotein 17-1A, exhibiting antitumor activity by recognizing the human tumor-associated antigen Ep-CAM. It is used in studies of colorectal cancer. |
| 体外活性 | Edrecolomab 显著抑制人结肠癌 HT-29 系肿瘤的生长。[1] |
| 体内活性 | Edrecolomab (30μg /dose,静脉注射)处理,在 HT-29 裸鼠模型中抑制肿瘤的生长。[1] |
| 别名 | 依决洛单抗, Panorex, M-17-1A, CO17-1A, CO171A, 17-1A, 1083 17-1A |
| CAS No. | 156586-89-9 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容